Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Marksans Pharma Limited ( (IN:MARKSANS) ) just unveiled an announcement.
Marksans Pharma Limited has announced the appointment of M/s Jinesh Dedhia & Associates as the Secretarial Auditor for a five-year term starting from April 1, 2025, to March 31, 2030. This strategic move is part of the company’s compliance with regulatory requirements and aims to enhance its governance practices, potentially strengthening its market position and stakeholder confidence.
More about Marksans Pharma Limited
Marksans Pharma Limited is a company operating in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceutical products. The company serves various markets, including domestic and international sectors, with a range of therapeutic products.
Average Trading Volume: 100,455
Current Market Cap: 117.3B INR
For an in-depth examination of MARKSANS stock, go to TipRanks’ Overview page.